Early research (Phase 1)Study completedNCT00093821
What this trial is testing
Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Who this might be right for
Childhood Chronic Myelogenous LeukemiaChildhood Desmoplastic Small Round Cell TumorDisseminated Neuroblastoma+11 more
National Cancer Institute (NCI) 70